Literature DB >> 8181356

Pulmonary plasma cell granuloma improves with corticosteroid therapy.

T Bando1, M Fujimura, Y Noda, J Hirose, G Ohta, T Matsuda.   

Abstract

Two cases of pulmonary plasma cell granuloma that progressed after respiratory infectious disease are described. The men, 48 and 32 years old, were admitted to the hospital with blood-streaked sputum and mass or nodular shadow on chest radiograph. Close examination revealed that these tumors were plasma cell granulomas, which are known as postinflammatory pseudotumors. Biopsy specimens, obtained by way of transbronchial biopsy, demonstrated proliferation of mature plasma cells and infiltration of lymphocytes supported by granulation tissue, and there was no evidence of malignancy or tuberculosis. Although surgery is common in the treatment of pulmonary plasma cell granuloma, some cases relapse or invade the mediastinum. Therefore, we decided to treat these patients with prednisolone, 30 mg/d, an anti-inflammatory and immunosuppressive agent. Two or 4 weeks later, these tumors disappeared completely and they have never recurred. As middle-dosage corticosteroid therapy is not cytotoxic, it is useful for the treatment of pulmonary plasma cell granuloma, especially in multifocal, unresectable, and/or relapsing cases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181356     DOI: 10.1378/chest.105.5.1574

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  [Inflammatory myofibroblastic tumor of the lymph node with paraneoplastic thrombosis and eosinophilia].

Authors:  Ali Behzad; Andrea Müller; Wolf Rösler; Kerstin Amann; Rainer Linke; Andreas Mackensen
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Cardiac plasma cell granulomas: response to oral steroid treatment.

Authors:  P Ferbend; L P Abramson; C L Backer; C Mavroudis; C L Webb; J A Doll; J J Junewick; S E Crawford
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

3.  [Thoracic inflammatory pseudotumors : A rare differential diagnosis].

Authors:  S Sponholz; M Schirren; N Baldes; L Schreiner; A Fisseler-Eckhoff; J Schirren
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

4.  Bilateral multiple inflammatory myofibroblastic tumors of the lung successfully treated with corticosteroids.

Authors:  Min Hee Lee; Heung Bum Lee; Yong Chul Lee; Yang Keun Rhee; Eun Jung Lee; Myoung Ja Chung; Gong Yong Jin; Eui Yong Kweon; Seoung Ju Park
Journal:  Lung       Date:  2011-08-02       Impact factor: 2.584

5.  Inflammatory pseudotumor of the lung: clinicopathological analysis in seven adult patients.

Authors:  Yoshihiro Kobashi; Minoru Fukuda; Masao Nakata; Tsutomu Irei; Mikio Oka
Journal:  Int J Clin Oncol       Date:  2006-12-25       Impact factor: 3.402

6.  Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.

Authors:  Kazunori Honda; Shigenori Kadowaki; Kyoko Kato; Nobuhiro Hanai; Yasuhisa Hasegawa; Yasushi Yatabe; Kei Muro
Journal:  Invest New Drugs       Date:  2019-02-21       Impact factor: 3.850

Review 7.  Clinical and Histopathologic Correlates and Management Strategies for Inflammatory Myofibroblastic tumor of the lung. A case series and review of the literature.

Authors:  Ala Eddin S Sagar; Carlos A Jimenez; Vickie R Shannon
Journal:  Med Oncol       Date:  2018-06-04       Impact factor: 3.064

8.  Inflammatory Pseudotumor of the Lung: A Rare Presentation with Complete Regression to Pharmacotherapy.

Authors:  Jinyung Ju
Journal:  Chonnam Med J       Date:  2017-09-25

9.  Surgical management of pulmonary inflammatory pseudotumors: a single center experience.

Authors:  Baldassare Mondello; Salvatore Lentini; Mario Barone; Pietro Barresi; Francesco Monaco; Dario Familiari; Annunziata La Rocca; Michele Sibilio; Ignazio Eduardo Acri; Antonio David; Maurizio Monaco
Journal:  J Cardiothorac Surg       Date:  2011-02-23       Impact factor: 1.637

10.  Surgery for recurrent inflammatory pseudotumor of the lung.

Authors:  Taichiro Goto; Kumi Akanabe; Arafumi Maeshima; Ryoichi Kato
Journal:  World J Surg Oncol       Date:  2011-10-18       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.